|
Volumn 20, Issue 6, 2012, Pages 1947-1951
|
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs
|
Author keywords
Cancer cell line panel; COMPARE analysis; Drug discovery and development; JFCR39; ZSTK474
|
Indexed keywords
1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE;
1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE;
2 (2 DIFLUOROMETHYLBENZIMIDAZOL 1 YL) 4,6 DIMORPHOLINO 1,3,5 TRIAZINE;
2 MORPHOLINO 8 PHENYLCHROMONE;
ANTINEOPLASTIC AGENT;
BAICALEIN;
E 7107;
FJ 5002;
MS 247;
PICTRELISIB;
PLADIENOLIDE B;
UNCLASSIFIED DRUG;
ALGORITHM;
ANTINEOPLASTIC ACTIVITY;
BRAIN CANCER;
BREAST CANCER;
CANCER CELL CULTURE;
CANCER INHIBITION;
COLON CANCER;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TARGETING;
HIGH THROUGHPUT SCREENING;
HUMAN;
KIDNEY CANCER;
LUNG CANCER;
MELANOMA;
NEOPLASM;
NONHUMAN;
OVARY CANCER;
PROSTATE CANCER;
REVIEW;
STOMACH CANCER;
|
EID: 84857913967
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.01.017 Document Type: Article |
Times cited : (56)
|
References (25)
|